Double Protease Inhibitor to Darunavir Switch Study
NCT00531557
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Darunavir ritonavir
Sponsor
St Stephens Aids Trust